Literature DB >> 10784126

A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy.

R C Chang1, C Rota, R E Glover, R P Mason, J S Hong.   

Abstract

Microglia as the first line of defensive cells in the brain produce free radicals including superoxide and nitric oxide (NO), contributing to neurodegeneration. An opioid receptor antagonist, naloxone, has been considered pharmacologically beneficial to endotoxin shock, experimental cerebral ischemia, and spinal cord injury. However, the mechanisms underlying these beneficial effects of naloxone are still not clear. This study explores the effects of naloxone on the production of superoxide and NO by the murine microglial cell line, BV2, stimulated with lipopolysaccharide (LPS) as measured by electron paramagnetic resonance (EPR). The production of superoxide triggered by phobol-12-myristate-13-acetate (PMA) resulted in superoxide dismutase (SOD)-inhibitable, catalase-uninhibitable 5,5-dimethyl-1-pyrroline N-oxide (DMPO) hydroxyl radical adduct formation. LPS enhanced the production of superoxide and triggered the formation of non-heme iron-nitrosyl complex. Cells pre-treated with naloxone showed significant reduction of superoxide production by 35%. However, it could not significantly reduce the formation of non-heme iron-nitrosyl complex and nitrite. Taken together, the results expand our understanding of the neuroprotective effects of naloxone as it decreases superoxide production by microglia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784126     DOI: 10.1016/s0006-8993(99)02267-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 2.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 3.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 4.  Neuropsychopharmacological understanding for therapeutic application of morphinans.

Authors:  Eun-Joo Shin; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

5.  Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.

Authors:  Jen-Hsin Kao; Man-Jun Gao; Pao-Pao Yang; Ping-Yee Law; Horace H Loh; Pao-Luh Tao
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

Review 6.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

7.  Cadmium-induced toxicity in rat primary mid-brain neuroglia cultures: role of oxidative stress from microglia.

Authors:  Zhengqin Yang; Sufen Yang; Steven Y Qian; Jau-Shyong Hong; Maria B Kadiiska; Raymond W Tennant; Michael P Waalkes; Jie Liu
Journal:  Toxicol Sci       Date:  2007-05-05       Impact factor: 4.849

8.  The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

9.  Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells.

Authors:  Ashutosh Kumar; Shih-Heng Chen; Maria B Kadiiska; Jau-Shyong Hong; Jacek Zielonka; Balaraman Kalyanaraman; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2014-04-16       Impact factor: 7.376

10.  Pilot study of tolerability and safety of opioid receptor antagonists as novel therapies for chronic pain among persons living with HIV with past year heavy drinking: a randomized controlled trial.

Authors:  Sally Bendiks; Debbie M Cheng; Elena Blokhina; Marina Vetrova; Elena Verbitskaya; Natalia Gnatienko; Kendall Bryant; Evgeny Krupitsky; Jeffrey H Samet; Judith I Tsui
Journal:  AIDS Care       Date:  2021-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.